These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


303 related items for PubMed ID: 15890372

  • 1. Mechanisms of mu opioid receptor/G-protein desensitization in brain by chronic heroin administration.
    Maher CE, Martin TJ, Childers SR.
    Life Sci; 2005 Jul 22; 77(10):1140-54. PubMed ID: 15890372
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cocaine alters mu but not delta or kappa opioid receptor-stimulated in situ [35S]GTPgammaS binding in rat brain.
    Schroeder JA, Niculescu M, Unterwald EM.
    Synapse; 2003 Jan 22; 47(1):26-32. PubMed ID: 12422370
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chronic antidepressant treatment causes a selective reduction of mu-opioid receptor binding and functional coupling to G Proteins in the amygdala of fawn-hooded rats.
    Chen F, Lawrence AJ.
    J Pharmacol Exp Ther; 2004 Sep 22; 310(3):1020-6. PubMed ID: 15121763
    [Abstract] [Full Text] [Related]

  • 7. Chronic ethanol consumption reduces delta-and mu-opioid receptor-stimulated G-protein coupling in rat brain.
    Saland LC, Abeyta A, Frausto S, Raymond-Stintz M, Hastings CM, Carta M, Valenzuela CF, Savage DD.
    Alcohol Clin Exp Res; 2004 Jan 22; 28(1):98-104. PubMed ID: 14745307
    [Abstract] [Full Text] [Related]

  • 8. Effects of intracerebroventricular administration of beta-funaltrexamine on DAMGO-stimulated [35S]GTP-gamma-S binding in rat brain sections.
    Martin TJ, Sim LJ, Selley DE, deMontis MG, Childers SR.
    Synapse; 1997 Nov 22; 27(3):177-82. PubMed ID: 9329153
    [Abstract] [Full Text] [Related]

  • 9. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM, Qian X, Schiller PW, Szeto HH.
    J Pharmacol Exp Ther; 2003 Dec 22; 307(3):947-54. PubMed ID: 14534366
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential regional effects of methadone maintenance compared to heroin dependence on mu-opioid receptor desensitization in rat brain.
    Martin TJ, Kahn WR, Xiao R, Childers SR.
    Synapse; 2007 Mar 22; 61(3):176-84. PubMed ID: 17152089
    [Abstract] [Full Text] [Related]

  • 12. Mu opioid receptor coupling to Gi/o proteins increases during postnatal development in rat brain.
    Talbot JN, Happe HK, Murrin LC.
    J Pharmacol Exp Ther; 2005 Aug 22; 314(2):596-602. PubMed ID: 15860573
    [Abstract] [Full Text] [Related]

  • 13. Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain.
    Sim-Selley LJ, Selley DE, Vogt LJ, Childers SR, Martin TJ.
    J Neurosci; 2000 Jun 15; 20(12):4555-62. PubMed ID: 10844025
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord.
    Madia PA, Navani DM, Yoburn BC.
    Pharmacol Biochem Behav; 2012 Mar 15; 101(1):155-65. PubMed ID: 22108651
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mu and kappa1 opioid-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in cynomolgus monkey brain.
    Sim-Selley LJ, Daunais JB, Porrino LJ, Childers SR.
    Neuroscience; 1999 Mar 15; 94(2):651-62. PubMed ID: 10579225
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
    Neilan CL, Janvey AJ, Bolan E, Berezowska I, Nguyen TM, Schiller PW, Pasternak GW.
    J Pharmacol Exp Ther; 2003 Aug 15; 306(2):430-6. PubMed ID: 12663687
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.